Is there Pomalidomide produced in India?

It is understood that Pomalidomide produced in India belongs to the category of generic drugs. Its pharmaceutical ingredients are basically the same as those of the original Pomalidomide drug, but the price is cheaper than the original drug. The price of each box produced by NATCO in India may be around 2,000 yuan.

Pomalidomide is an imide with antimyeloma properties, including anti-inflammatory, anti-angiogenic, anti-proliferative, and immunomodulatory effects. The in vitro effects of imines are diverse, and the exact mechanism of each corresponding effect of their activity against multiple myeloma (MM) remains unclear. However, based on in vitro data, the most critical mechanism of action of imine drugs is to disrupt the MM-bone marrow stromal cell (BMSC) interaction. This results in the downregulation of key cytokines and growth factors necessary for myeloma growth. During treatment with pomalidomide, patients must have a neutrophil count ≥500/L and a platelet count ≥50,000/L.

Pomalidomide, independently developed in China, has been launched domestically and has now entered the scope of medical insurance. The price of domestically produced Pomalidomide may be around RMB 4,000 per box, while the Turkish version sold overseas may be priced around RMB 15,000 per box (the price may fluctuate due to exchange rates), which is relatively expensive. There are also cheaper generic drugs produced in other countries overseas. The price of each box produced by a Lao pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to the exchange rate). The ingredients of foreign generic drugs, domestically produced drugs and foreign original drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.